We have previously looked at a review and a number of studies addressing the issue of oral hygiene and ventilator-associated pneumonia (VAP) and (Dental Elf May 20th 2013). A new Cochrane review has just been published which aimed to assess the effects of oral hygiene care (OHC) on the incidence of VAP in critically ill [read the full story…]
Ventilator-associated pneumonia (VAP) is a life-threatening condition in critically ill patients receiving mechanical ventilation. Incidence rates vary between 9% and 45% and it carries a significant mortality risk. The oropharynx and upper gastrointestinal tract are the main reservoirs for the associated pathogens. The aim of this review was to evaluate the effects of oral care [read the full story…]
Ventilator-associated pneumonia (VAP) can be life threatening and its link with good mouth care is a topic we have covered before on Dental Elf (18th April 2012 and 28th Nov 2011). The aim of this study was to evaluate whether oral swabbing with 0.2% chlorhexidine gluconate (CHX) decreases the risk of ventilator-associated pneumonia (VAP) in [read the full story…]
A number of previous studies have highlighted the risk of poor oral health as a potential risk factor for aspirational pneumonia in frail older people. The aim of this review was to review the literature on oral health care interventions in frail older people and the effect on the incidence of aspiration pneumonia. The authors [read the full story…]
For critically ill patients receiving mechanical ventilation, ventilator-associated pneumonia (VAP) is a life threatening condition. Incidence rates varies and mortality rates can be as high as 50% . The aim of this study was to evaluate the effects brushing teeth twice daily with purified water on VAP rates and oral health or hygiene in postneurosurgical, [read the full story…]
Ventilator-associated pneumonia (VAP) is a life-threatening condition in critically ill patients receiving mechanical ventilation. The incidence of VAP in varies between 9% and 45% with mortality rates of up to 50% . It is accompanied by an increase both in length of stay in intensive care units ICU and healthcare. The aim of this trial [read the full story…]
